{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:40:11Z","timestamp":1777963211757,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016206","name":"Clinical and Translational Science Institute, University of California, Los Angeles","doi-asserted-by":"publisher","award":["UL1TR001881"],"award-info":[{"award-number":["UL1TR001881"]}],"id":[{"id":"10.13039\/100016206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insufficient research has been done on NASH-related cirrhosis mortality and potential racial disparities in mortality rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to analyze racial differences in mortality rates among patients with non-alcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH), hypothesizing that hazard ratios for mortality among patients with NAFLD, NAFL, and NASH would be significantly different for Mexican American patients compared to other racial groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from NHANES III (1988\u20131994) representing the U.S. population were analyzed. Bivariate analysis and Cox proportional hazards models were employed to determine mortality rates and predictors across different racial\/ethnic groups, adjusting for variables age, gender, smoking status (current, former, non-smoker), BMI (normal, overweight, obese), and a series of biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of liver diseases in the sample was: NAFLD (12.1%), NAFL (20.0%), and NASH (3.1%). Deceased patients with NASH had the highest weighted mortality rate (50.6%), followed by NAFLD (39.1%) and NAFL (35.5%). Compared to White patients, Black and Mexican American patients exhibited lower mortality rates for NAFLD. Mexican American patients also had lower mortality rates for NFAL and NASH. White patients showed higher hazard ratios (HR) for NAFLD and NAFL compared to Black and Mexican\u2013American patients. However, for NASH, there were no significant differences in HR between racial\/ethnic groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite higher prevalence rates among Mexican American and Black patients, their mortality rates for NAFLD, NAFL, and NASH were comparable or lower than those for Whites. This highlights the need for further research to inform better management and treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40615-025-02317-9","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T09:32:08Z","timestamp":1741080728000},"page":"1083-1093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis: Insights from NHANES III Data"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-5198","authenticated-orcid":false,"given":"Shahrzad","family":"Bazargan-Hejazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Hines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Argueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arleen F.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2317_CR1","unstructured":"https:\/\/www.niddk.nih.gov\/health-information\/liver-disease\/nafld-nash\/definition-facts (accessed December 30, 2024."},{"issue":"24","key":"2317_CR2","doi-asserted-by":"publisher","first-page":"35632","DOI":"10.18632\/oncotarget.9691","volume":"7","author":"L Wang","year":"2016","unstructured":"Wang L, Guo J, Lu J. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. Oncotarget. 2016;7(24):35632\u201342. https:\/\/doi.org\/10.18632\/oncotarget.9691. (in eng).","journal-title":"Oncotarget"},{"issue":"22","key":"2317_CR3","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: A systematic review. JAMA. 2015;313(22):2263\u201373. https:\/\/doi.org\/10.1001\/jama.2015.5370.","journal-title":"JAMA"},{"issue":"12","key":"2317_CR4","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/jgh.12665","volume":"29","author":"M Otgonsuren","year":"2014","unstructured":"Otgonsuren M, et al. A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). J Gastroenterol Hepatol. 2014;29(12):2006\u201313. https:\/\/doi.org\/10.1111\/jgh.12665.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"2317_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005\u201323. https:\/\/doi.org\/10.1002\/hep.25762. (in eng).","journal-title":"Hepatology"},{"issue":"1","key":"2317_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, et al. \u201cPrevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study,\u201d (in eng). Gastroenterology. 2011;140(1):124\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2010.09.038.","journal-title":"Gastroenterology"},{"issue":"S1","key":"2317_CR7","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology. 2006;43(S1):S99\u2013112. https:\/\/doi.org\/10.1002\/hep.20973.","journal-title":"Hepatology"},{"key":"2317_CR8","doi-asserted-by":"publisher","first-page":"g4596","DOI":"10.1136\/bmj.g4596","volume":"349","author":"N Sattar","year":"2014","unstructured":"Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. Bmj. 2014;349:g4596. https:\/\/doi.org\/10.1136\/bmj.g4596. (in eng).","journal-title":"Bmj"},{"issue":"6","key":"2317_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510\u20139.","journal-title":"Obes Rev"},{"issue":"6","key":"2317_CR10","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/hep.30094","volume":"68","author":"AM Allen","year":"2018","unstructured":"Allen AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, McCoy RG. Healthcare cost and utilization in nonalcoholic fatty liver disease: Real-world data from a large U.S. claims database. Hepatology. 2018;68(6):2230\u20138. https:\/\/doi.org\/10.1002\/hep.30094.","journal-title":"Hepatology"},{"issue":"1","key":"2317_CR11","doi-asserted-by":"publisher","first-page":"11124","DOI":"10.1038\/s41598-019-47687-3","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhong G-C, Tan H-Y, Hao F-B, Hu J-J. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. Sci Rep. 2019;9(1):11124. https:\/\/doi.org\/10.1038\/s41598-019-47687-3.","journal-title":"Sci Rep"},{"issue":"3","key":"2317_CR12","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/hep.30161","volume":"69","author":"D Kim","year":"2019","unstructured":"Kim D, et al. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69(3):1064\u201374. https:\/\/doi.org\/10.1002\/hep.30161.","journal-title":"Hepatology"},{"issue":"8","key":"2317_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1530-0277.2001.tb02333.x","volume":"25","author":"FS Stinson","year":"2001","unstructured":"Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol: Clin Exp Res. 2001;25(8):1181\u20137.","journal-title":"Alcohol: Clin Exp Res"},{"issue":"2","key":"2317_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis. 2016;20(2):205\u201314.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"2317_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/cld.948","volume":"16","author":"NS Samji","year":"2020","unstructured":"Samji NS, Snell PD, Singal AK, Satapathy SK. Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken). Aug2020;16(2):66\u201372. https:\/\/doi.org\/10.1002\/cld.948.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2317_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","volume":"61","author":"ZA Sherif","year":"2016","unstructured":"Sherif ZA, et al. Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations. Dig Dis Sci. 2016;61:1214\u201325.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"2317_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2174\/1381612826666200303114934","volume":"26","author":"T Arshad","year":"2020","unstructured":"Arshad T, Golabi P, Henry L, Younossi ZM. Epidemiology of non-alcoholic fatty liver disease in North America. Curr Pharm Des. 2020;26(10):993\u20137.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"2317_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich NE, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(2):198-210e2. https:\/\/doi.org\/10.1016\/j.cgh.2017.09.041.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2317_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis. 2016;20(2):205\u201314. https:\/\/doi.org\/10.1016\/j.cld.2015.10.001.","journal-title":"Clin Liver Dis"},{"issue":"4","key":"2317_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/0739986313499004","volume":"35","author":"SA Teruya","year":"2013","unstructured":"Teruya SA, Bazargan-Hejazi S. The immigrant and hispanic paradoxes: A systematic review of their predictions and effects. Hisp J Behav Sci. 2013;35(4):486\u2013509. https:\/\/doi.org\/10.1177\/0739986313499004.","journal-title":"Hisp J Behav Sci"},{"issue":"5","key":"2317_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10903-024-01604-7","volume":"26","author":"N Abu-Freha","year":"2024","unstructured":"Abu-Freha N, et al. Nonalcoholic fatty liver disease and ethnicity: Lessons learned from the Arab population in Israel. J Immigr Minor Health. 2024;26(5):859\u201365.","journal-title":"J Immigr Minor Health"},{"issue":"1","key":"2317_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"Suppl","key":"2317_CR23","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2022","unstructured":"Gofton C, Upendran Y, Zheng M-H, George J. MAFLD: How is it different from NAFLD? Clin Mol Hepatol. 2022;29(Suppl):S17.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"2317_CR24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"J-G Fan","year":"2017","unstructured":"Fan J-G, Kim S-U, Wong VW-S. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862\u201373. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.003.","journal-title":"J Hepatol"},{"issue":"11","key":"2317_CR25","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1111\/liv.15404","volume":"42","author":"VWS Wong","year":"2022","unstructured":"Wong VWS, et al. Management of NAFLD in primary care settings. Liver Int. 2022;42(11):2377\u201389. https:\/\/doi.org\/10.1111\/liv.15404.","journal-title":"Liver Int"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-025-02317-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:09:05Z","timestamp":1772809745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-025-02317-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1007\/s40615-025-02317-9","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is observational and uses publicly available data. The CDU Institutional Review Board has confirmed that no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}